| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 |
| filingDate |
1995-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c39d917984ef1cadb4b2bc50fda03705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6957705f52d551a22117e5ccf2e9dec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84e74a9802faa12bcb4721f4ac313e2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5bf97dd61307d1f2cc1925026ef54f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abaf826247ee923c5fe20cd626df3672 |
| publicationDate |
2001-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-419464-B |
| titleOfInvention |
Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments |
| abstract |
The application relates to substituted 4-phenyl-6-amino-nicotinic acid derivatives for therapeutic use, to novel active compounds and to their use as cerebrally active agents. The active compounds are prepared by oxidizing appropriately substituted dihydropyridines according to customary methods. |
| priorityDate |
1994-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |